Results 281 to 290 of about 9,546,669 (393)

Nephrotoxicity of Immune Checkpoint Inhibitors in Single and Combination Therapy-A Systematic and Critical Review. [PDF]

Biomedicines
Tascón J, Casanova AG, Vicente-Vicente L, López-Hernández FJ, Morales AI.   +4 more
europepmc   +1 more source

Efficacy of combination therapy with mexiletine and a low dose of propranolol for premature ventricular arrhythmias.

, 1990
Akira Kobayashi, Noboru Yamazaki, Tadashi Kobayashi, Tsutomu Watanabe, Takayuki Ito, Koichi Ogawa   +5 more
openalex   +2 more sources

Adenosine A3 receptor antagonists as anti‐tumor treatment in human prostate cancer: an in vitro study

FEBS Open Bio, EarlyView.
The A3 adenosine receptors (A3ARs) are overexpressed in prostate cancer. AR 292 and AR 357, as A3AR antagonists, are capable of blocking proliferation, modulating the expression of drug transporter genes involved in chemoresistance, ferroptosis, and the hypoxia response, and inducing cell death.
Maria Beatrice Morelli, Andrea Spinaci, Cui Chang, Rosaria Volpini, Catia Lambertucci, Matteo Landriscina, Vincenza Conteduca, Consuelo Amantini, Cristina Aguzzi, Laura Zeppa, Martina Giangrossi, Laura Soverchia, Matteo Santoni, Massimo Nabissi, Giorgio Santoni, Carlo Polidori   +15 more
wiley   +1 more source

First-Line Immune-Combination Therapy for Driver Gene-Negative NSCLC With Brain Metastases: Real-World Outcomes. [PDF]

Thorac Cancer
You M, Wu L, Liu J, Yuan H, Wang Z, Hao X, Xing P, Li J.   +7 more
europepmc   +1 more source

A case of plantar malignant melanoma showing remission by combination with TCA therapy.

, 1990
Toshinao Ishii
openalex   +2 more sources

Downregulation of O‐GlcNAcylation enhances etoposide‐induced p53‐mediated apoptosis in HepG2 human liver cancer cells

FEBS Open Bio, EarlyView.
Etoposide, a topoisomerase II inhibitor, reduces O‐GlcNAcylation in HepG2 liver cancer cells. Further inhibition of O‐GlcNAc transferase by OSMI‐1 enhanced etoposide‐induced apoptosis, lowering the IC50 for viability and increasing the EC50 for cytotoxicity.
Jaehoon Lee, Gi‐Bang Koo, Jihye Park, Byung‐Cheol Han, Mijin Kwon, Seung‐Ho Lee   +5 more
wiley   +1 more source

A heart for the Islands: The role of fixed-dose combination therapy in the Philippines' fight against premature CVD deaths. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Lacsa JEM.
europepmc   +1 more source

Fundamental study of combination therapy with UFT and irradiation.

, 1990
Ryoso ARIMORI
openalex   +2 more sources

Combination antifungal therapy

Pediatric Infectious Disease Journal, 2003
openaire   +4 more sources

Advanced glycation end products promote the release of endothelial cell‐derived mitocytosis

FEBS Open Bio, EarlyView.
Under diabetic conditions, AGEs induce mitochondrial damage in HUVECs, activating migrasome‐mediated mitocytosis. Migrasomes encapsulate damaged mitochondria and are released into the extracellular space, facilitating intercellular mitochondrial transfer.
Rong Liu, Yuhao Zhang, Tiantian Ge, Hao Wu, Yongbin Ma, Honghua Ye, Fei Guo   +6 more
wiley   +1 more source